.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Julphar
Novartis
Boehringer Ingelheim
Baxter
Dow
QuintilesIMS
McKinsey
Fuji
Healthtrust

Generated: December 14, 2017

DrugPatentWatch Database Preview

DILTIAZEM HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Diltiazem Hydrochloride patents expire, and what generic alternatives are available?

Diltiazem Hydrochloride is a drug marketed by Actavis Elizabeth, Actavis Labs Fl Inc, Apotex, Biovail, Mylan, Nesher Pharms, Par Pharm, Sandoz, Sun Pharm Inds Ltd, Sun Pharma Global, Teva, Valeant Pharms North, Zydus Pharms Usa Inc, Akorn Inc, Athenex Inc, Hikma Farmaceutica, Hospira, Intl Medication, Mylan Labs Ltd, Teva Pharms Usa, West-ward Pharms Int, Apothecon, Chartwell Molecules, Ivax Sub Teva Pharms, and Teva Pharms. and is included in thirty-six NDAs.

The generic ingredient in DILTIAZEM HYDROCHLORIDE is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
Drug patent expirations by year for DILTIAZEM HYDROCHLORIDE

Pharmacology for DILTIAZEM HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Akorn IncDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideINJECTABLE;INJECTION075086-001Apr 9, 1998APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideTABLET;ORAL072838-004Nov 5, 1992ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharm Inds LtdDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL203023-003Jun 8, 2017AB3RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL074984-004Dec 20, 1999AB3RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Labs Fl IncDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL077686-003Mar 15, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva PharmsDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideTABLET;ORAL074067-004Nov 5, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL090492-003Oct 28, 2011AB3RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Teva PharmsDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideTABLET;ORAL074067-001Nov 5, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Valeant Pharms NorthDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL075116-004Dec 23, 1999AB3RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL090492-001Oct 28, 2011AB3RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DILTIAZEM HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
BiovailDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020939-004Jan 28, 2000► Subscribe► Subscribe
BiovailDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020939-001Jan 28, 2000► Subscribe► Subscribe
BiovailDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020939-004Jan 28, 2000► Subscribe► Subscribe
BiovailDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020939-003Jan 28, 2000► Subscribe► Subscribe
BiovailDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020939-002Jan 28, 2000► Subscribe► Subscribe
BiovailDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020939-003Jan 28, 2000► Subscribe► Subscribe
BiovailDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020939-002Jan 28, 2000► Subscribe► Subscribe
BiovailDILTIAZEM HYDROCHLORIDEdiltiazem hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL020939-001Jan 28, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Julphar
US Army
Dow
Covington
Moodys
Citi
Argus Health
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot